AAPS National Biotech Conference

Patients

Mehul Desai, VP of medical affairs at Enable Injections, sat down with pharmaphorum editor-in-chief Jonah Comstock at AAPS.

News

A $100m trial has been launched to see if lifestyle changes coupled with GLP-1 agonists or similar incretins can reduce the risk of dementia.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.